Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Accenture
Fish and Richardson
Medtronic
Cipla
Julphar
Chubb
Dow
Mallinckrodt

Generated: May 21, 2018

DrugPatentWatch Database Preview

AMITRIL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Amitril patents expire, and what generic alternatives are available?

Amitril is a drug marketed by Warner Chilcott and is included in six NDAs.

The generic ingredient in AMITRIL is amitriptyline hydrochloride. There are thirteen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the amitriptyline hydrochloride profile page.
Summary for AMITRIL
Drug patent expirations by year for AMITRIL
Medical Subject Heading (MeSH) Categories for AMITRIL
Synonyms for AMITRIL
(3-(5,6-dihydrodibenzo[b,f][7]annulen-11-ylidene)propyl)dimethylamine
[3-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidene)-propyl]-dimethyl-amine
1-Propanamine, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-
1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-
10,11-Dihydro-5-(.gamma.-dimethylaminopropylidene)-5H-dibenzo(a,d)cycloheptene
10,11-Dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo(a,d)cycloheptene
10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo[a,d]cycloheptene
10,11-dihydro-N,N-dimethl-5H-dibenzo[a,d]cycloheptene-(delta(5, gamma))-propylamine
10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-.DELTA.5,.gamma.-propylamine
10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-delta(5),gamma-propylamine
10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-delta(sup 5),gamma-propylamine
1409-EP2269989A1
1409-EP2275420A1
1409-EP2277861A1
1409-EP2298313A1
1409-EP2298731A1
1409-EP2298764A1
1409-EP2298765A1
1409-EP2305652A2
1409-EP2305669A1
1409-EP2314585A1
17086-03-2 (pamoate (2:1))
1806D8D52K
3-(10,11-Dihydro-5H-dibenzo-[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine, hydrochloride
3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-yliden)-N,N-dimethylpropylamin
3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine
3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethyl-1-propanamine
3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine
3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine
3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine
3-(5,6-dihydrodibenzo[[?],[?]][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine
30227-34-0 (maleate (1:1))
412A072
5-(.gamma.-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene
5-(.gamma.-Dimethylaminopropylidene)-5H-dibenzo(a,d)-10,11-dihydrocycloheptene
5-(.gamma.-Dimethylaminopropylidene)-5H-Dibenzo[a,d][1,4]cycloheptadiene
5-(.gamma.-Dimethylaminopropylidine)-5H-dibenzo(a,d)(1,4)cycloheptadiene
5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptatriene
5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene
5-(3-Dimethylaminopropylidene)-5H-dibenzo[a,d]-10,11-dihydrocycloheptene
5-(3-dimethylaminopropylidene)dibenzo[a,d][1,4]-cycloheptadiene
5-(3'-Dimethylaminopropylidene)-dibenzo-(a,d)(1,4)-cycloheptadiene
5-(3'-Dimethylaminopropylidene)-dibenzo-[a,d][1,4]-cycloheptadiene
5-(gamma-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene
5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,d)(1,4)cycloheptadiene
5-(gamma-Dimethylaminopropylidene)-5H-Dibenzo[a,d][1,4]cycloheptadiene
5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,d]10,11-dihydrocycloheptene
5-(gamma-Dimethylaminopropylidine)-5H-dibenzo(a,d)(1,4)cycloheptadiene
50-48-6
549-18-8 (hydrochloride)
5H-Dibenzo(a,d)cycloheptene-.delta.(sup 5),.gamma.-propylamine, 10,11-dihydro-N,N-dimethyl-
5H-Dibenzo(a,d)cycloheptene-delta(sup 5),gamma-propylamine, 10,11-dihydro-N,N-dimethyl-
5H-Dibenzo(a,d)cycloheptene-delta5,gamma-propylamine, 10,11-dihydro-N,N-dimethyl-
5H-Dibenzo[a,d]cycloheptene-.delta.5,.gamma.-propylamine, 10,11-dihydro-N,N-dimethyl-
5H-Dibenzo[a,d]cycloheptene-Delta5,gamma-propylamine, 10,11-dihydro-N,N-dimethyl- (6CI,8CI) 5-(gamma-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene
AB00053417_13
AB00053417_14
AB00053417-12
AB00514631
AC1L1D20
Adepress
Adepril
AK116439
AKOS000512694
Amitriprolidine
Amitriptilina
Amitriptilina [INN-Spanish]
Amitriptilina [Italian]
Amitriptylin
Amitriptylin [German]
amitriptyline
Amitriptyline (INN)
Amitriptyline [INN:BAN]
Amitriptylinum
Amitriptylinum [INN-Latin]
Amitryptiline
amitryptiline HCl
Amitryptyline
Amytriptiline
Amytriptylin
AN-41559
API0001457
ARONIS24381
BAS 00269727
BBC/541
BBL028529
BC203219
BDBM50020712
BIDD:GT0115
BPBio1_000317
BRD-K53737926-003-05-4
BRN 2217885
BSPBio_000287
BSPBio_001836
C06824
CAS-549-18-8
CCG-204207
CCRIS 9174
CHEBI:2666
CHEMBL629
cMAP_000001
D07448
D0Y5UG
Damilan
Damilen
Damitriptyline
DB00321
dimethyl({3-[(2E)-tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene]propyl})amine
dimethyl({3-[(2E)-tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene]propyl})amine
dimethyl({3-[(2Z)-tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene]propyl})amine
dimethyl({3-[(2Z)-tricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene]propyl})amine
DIMETHYL(3-{TRICYCLO[9.4.0.0(3),?]PENTADECA-1(15),3,5,7,11,13-HEXAEN-2-YLIDENE}PROPYL)AMINE
DivK1c_000766
Domical (Salt/Mix)
DTXSID7022594
EC 200-041-6
EINECS 200-041-6
Elanil
Elavil
Elavil (TN)
Endep
Flavyl
FT-0653242
GTPL200
HSDB 3007
IDI1_000766
KBio1_000766
KBio2_000424
KBio2_002261
KBio2_002992
KBio2_004829
KBio2_005560
KBio2_007397
KBio3_001336
KBio3_002741
KBioGR_000592
KBioGR_002261
KBioSS_000424
KBioSS_002262
KRMDCWKBEZIMAB-UHFFFAOYSA-N
L001041
Lantron
Laroxil
Laroxyl
Laroxyl (Salt/Mix)
Laroxyl (TN)
Lentizol (Salt/Mix)
Lopac-A-8404
Lopac0_000112
LS-60747
MCULE-3537115467
MK 230
MolPort-001-662-651
MRF-0000533
N 750
NCGC00015095-01
NCGC00015095-02
NCGC00015095-03
NCGC00015095-04
NCGC00015095-05
NCGC00015095-06
NCGC00015095-07
NCGC00015095-08
NCGC00015095-09
NCGC00015095-10
NCGC00015095-11
NCGC00015095-12
NCGC00024433-04
NCGC00183047-01
NINDS_000766
NSC169910
Oprea1_479304
PDSP1_001564
PDSP2_001548
PL057663
Prestwick0_000074
Prestwick1_000074
Prestwick2_000074
Prestwick3_000074
Proheptadiene
Redomex
Ro 4-1575
Sarotex
SBB080793
SBI-0050100.P004
SCHEMBL7824
Seroten
SPBio_000082
SPBio_002208
Spectrum_000044
Spectrum2_000101
Spectrum3_000298
Spectrum4_000146
Spectrum5_000806
STK525215
STOCK1S-56825
Sylvemid
TP0
Triptanol
Triptilin
Triptisol
Triptizol (Salt/Mix)
Tryptanol
Tryptomer, Triplent(Talent India)
UNII-1806D8D52K
Vanatrip (Salt/Mix)
W-109252
ZINC968257
ZX-AS004743

US Patents and Regulatory Information for AMITRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Warner Chilcott AMITRIL amitriptyline hydrochloride TABLET;ORAL 083939-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Warner Chilcott AMITRIL amitriptyline hydrochloride TABLET;ORAL 084957-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Warner Chilcott AMITRIL amitriptyline hydrochloride TABLET;ORAL 083937-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Warner Chilcott AMITRIL amitriptyline hydrochloride TABLET;ORAL 083938-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
Fuji
Chinese Patent Office
Covington
Medtronic
Deloitte
Queensland Health
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.